PR Newswire BiotechOriginal article
PearlMatrix® P-15 Peptide Enhanced Bone Graft Receives Medicare New Technology Add-on Payment (NTAP), Helping Hospitals Accelerate Lumbar Fusion
RegulatoryapprovedPearlMatrix P-15 Peptide Enhanced Bone GraftPositive
AI Analysis
Summary
Cerapedics' PearlMatrix P-15 Peptide Enhanced Bone Graft received Medicare New Technology Add-on Payment (NTAP), providing additional reimbursement to hospitals for lumbar fusion procedures. The product is positioned as the first and only bone growth accelerator demonstrating superior lumbar fusion speed.
Outcome Details
Medicare New Technology Add-on Payment (NTAP) received for PearlMatrix P-15
Importance:6/10
Sentiment:
0.80
MedicarereimbursementNTAPbone graftlumbar fusionregulatory approval
Related Companies
Read the original article
Published by PR Newswire Biotech on October 1, 2026 5:56 PM
